Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Burn

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Molecular Cancer Therapeutics|February 4, 2010
Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumorsHolly K Koblish, Michael J Hansbury, Kevin J Bowman, et al.
Neurology. Genetics|May 26, 2016
Homozygous GNAL mutation associated with familial childhood-onset generalized dystoniaIkuo Masuho, Mingyan Fang, Chunyu Geng, et al.
Bioorganic & Medicinal Chemistry|June 14, 2006
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffoldEddy W Yue, Brian Wayland, Brent Douty, et al.
The Journal of Biological Chemistry|October 10, 2006
Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1BPaul J Ala, Lucie Gonneville, Milton Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severityPhillip C C Liu, Eian Caulder, Jun Li, et al.
The Journal of Biological Chemistry|August 19, 2006
Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimeticsPaul J Ala, Lucie Gonneville, Milton C Hillman, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma modelEddy W Yue, Brent Douty, Brian Wayland, et al.
Molecular Pharmacology|January 5, 2000
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramineL W Fitzgerald, T C Burn, B S Brown, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Nature Genetics|January 1, 1996
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmiasQ Wang, M E Curran, I Splawski, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Molecular Cancer Therapeutics|February 4, 2010
Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumorsHolly K Koblish, Michael J Hansbury, Kevin J Bowman, et al.
Neurology. Genetics|May 26, 2016
Homozygous GNAL mutation associated with familial childhood-onset generalized dystoniaIkuo Masuho, Mingyan Fang, Chunyu Geng, et al.
Bioorganic & Medicinal Chemistry|June 14, 2006
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffoldEddy W Yue, Brian Wayland, Brent Douty, et al.
The Journal of Biological Chemistry|October 10, 2006
Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1BPaul J Ala, Lucie Gonneville, Milton Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severityPhillip C C Liu, Eian Caulder, Jun Li, et al.
The Journal of Biological Chemistry|August 19, 2006
Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimeticsPaul J Ala, Lucie Gonneville, Milton C Hillman, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma modelEddy W Yue, Brent Douty, Brian Wayland, et al.
Molecular Pharmacology|January 5, 2000
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramineL W Fitzgerald, T C Burn, B S Brown, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Nature Genetics|January 1, 1996
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmiasQ Wang, M E Curran, I Splawski, et al.
Pageof 13